News & Notices

Find all the latest news and advances from QST Consultations here.

Current NewsNews ArchivesNews Press RSS Feed
  • Light the Night 2019

    On Saturday September 28, 2019, QST employees participated in the Leukemia and Lymphoma Society’s (LLS) annual event, Light the Night.

    Read More »
  • QST Appoints Phil Doren as CEO and Veronica Powell as COO

    QST Consultations, Ltd. announced today the appointment of Dr. Phil Doren as Chief Executive Officer. In July, 2018, Veronica Powell was promoted to the executive team as Chief Operating Officer.

    Read More »
  • QST Consultations, Ltd. Announces New Additions to Leadership Team

    QST Consultations, Ltd. was incorporated in 1985 to support pharmaceutical and medical device companies in their clinical research endeavors. QST specialized in clinical study design, clinical operations, DSMB meeting coordination, data management, biostatistical services, medical writing, and FDA consulting. QST has been instrumental in successful Phase I-IV and device trials integral to over 80 approved NDA, ANDA, PMA, and 510(k) submissions. QST’s primary focus is to meet the goals of each client through personalized service and technical expertise; we currently work with a range of sponsors that extend from small start-up organizations to well-established leaders in the pharmaceutical and medical device industries.

    Read More »
  • QST Consultations, Ltd. Honored as One of the 2013 “Michigan 50 Companies to Watch”

    QST Consultations, Ltd. was selected as one of Michigan's 50 Companies to Watch and will be honored at an awards ceremony during the ninth annual Michigan Celebrates Small Business event, May 2, 2013 in Lansing, Mich.

    Read More »